Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SCIENION Announces Launch of sciLINER

Published: Wednesday, November 13, 2013
Last Updated: Wednesday, November 13, 2013
Bookmark and Share
Line dispenser for membrane materials with full drop formation control at Medica 2013.

SCIENION AG has announced the launch of the sciLINER, the first dispenser to print lines on membranes with full visual drop detection.

With up to four channels, a minimum dispensing volume of 0.1 µl/cm and a flow rate of up to 8 ml/min the sciLINER represents an economical entry unit enabling the production of lateral flow devices or other membrane-based materials.

With its printing speed of 20 seconds per sheet it covers production from small to medium throughput. It can be operated in either aspirate dispense or bulk dispense modes to produce continuous lines with a width from 0.5 to 5 mm.

In contrast to current technologies, the sciLINER allows for the online monitoring of drop formation and offers integrated drop volume measuring.

Both are important features when sensitive biological materials such as antigens, antibodies or DNA are deposited on substrates used in the diagnostics industry.

The non-contact dispenser loads all membranes and flat targets with a size of up to 150 x 300 mm. “This is our first product specifically geared towards the point of care testing market”, says Dr. Holger Eickhoff, CEO of SCIENION AG.

Dr. Eickhoff continued, “As with all our technologies, this new technology does not only meet present needs for R&D efforts but, with drop control mechanisms, also forms the basis for a stable production of point of care tests based on membrane materials.”

Assays on membrane materials have become a very popular and versatile test format for rapid point of care diagnostics since their introduction in the mid-1980s. All kinds of biological samples can be tested, for example blood, serum, urine and, more recently, also saliva, sweat or tears if the sensitivity of the test is sufficient.

Typically these tests, especially in so called Lateral Flow Tests such as popular pregnancy strip tests (often referred to as “dipstick tests”) combine several advantages being quick and easy to use with no specific equipment required.

Eickhoff states: “Reproducibility in R&D and production is key to develop and produce reliable diagnostic tests. We are confident that the sciLINER, offering central dispense steps monitoring and control from test development to manufacturing, will help customers shorten time to market with their diagnostic products.”

The sciLINER will be exhibited at the SCIENION booth at MEDICA 2013, November 20-23 in Düsseldorf, Germany, booth 3A42 in hall 3.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
Scientific News
Autism, Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!